Combined with the expression of VEGF in SBLPE-treated tumor tissues, our data indicated that SBLPE may inhibit the growth and angiogenesis of H22 tumors by inhibiting the secretion of VEGF by tumor cells, therefore inhibiting the metastasis and proliferation of tumor cells. The gene discussed is VEGFA; the disease is neoplasm.